parasitology

News

Novartis says novel drug could counter malaria resistance

Novartis has reported what looks like another big step forward in the treatment of malaria, as a drug with a novel mechanism hits the mark in phase 3.

News

Pathogenic Acanthamoeba as seen under a light microscope

EU approves first therapy for acanthamoeba keratitis

The European Commission has approved SIFI's Akantior as the first therapy anywhere in the world for acanthamoeba keratitis (AK), an ultra-rare parasitic infection that can lead to blindness

News

Bayer drug raises hope for 1.5bn people with worm diseases

More than 1.5 billion people around the world are infected with soil-transmitted helminths (STHs), parasitic worms that damage their health and are a leading cause of maln

News

Novartis, MMV take new malaria drug combination into phase 3

Novartis and the non-profit Medicines for Malaria Venture (MMV) have advanced a novel drug combination for malaria into a phase 3 programme, raising hopes of a regimen that could be used to

News

GSK's malaria vaccine gets WHO okay for mass rollout

The WHO has given a green light to widespread use of GlaxoSmithKline's malaria vaccine in Africa, in what could be a major turning point in the fight against the disease.

News

Novartis drug raises hope of tackling malaria drug resistanc...

More than two decades ago , Novartis made a big contribution to the fight against malaria when it won approval for Coartem, the first artemisinin-based combination therapy (ACT), which has

Novartis says novel drug could counter malaria resistance

EU approves first therapy for acanthamoeba keratitis

Bayer drug raises hope for 1.5bn people with worm diseases

Novartis, MMV take new malaria drug combination into phase 3

GSK's malaria vaccine gets WHO okay for mass rollout

Novartis drug raises hope of tackling malaria drug resistanc...

NHS staff 'feel unprepared for digital transformation'

How to meet your physicians where they are online

parasitology

Editor's Picks